{"pmid":32341721,"pmcid":"PMC7181987","title":"[Nosocomial infection with SARS-Cov-2 within Departments of Digestive Surgery].","text":["[Nosocomial infection with SARS-Cov-2 within Departments of Digestive Surgery].","INTRODUCTION: The COVID-19 pandemic imposed a drastic reduction in surgical activity in order to respond to the influx of hospital patients and to protect uninfected patients by avoiding hospitalization. However, little is known about the risk of infection during hospitalization or its consequences. The aim of this work was to report a series of patients hospitalized on digestive surgery services who developed a nosocomial infection with SARS-Cov-2 virus. METHODS: This is a non-interventional retrospective study carried out within three departments of digestive surgery. The clinical, biological and radiological data of the patients who developed a nosocomial infection with SARS-Cov-2 were collected from the computerized medical record. RESULTS: From March 1, 2020 to April 5, 2020, among 305 patients admitted to digestive surgery services, 15 (4.9%) developed evident nosocomial infection with SARS-Cov-2. There were nine men and six women, with a median age of 62 years (35-68 years). All patients had co-morbidities. The reasons for hospitalization were: surgical treatment of cancer (n = 5), complex emergencies (n = 5), treatment of complications linked to cancer or its treatment (n = 3), gastroplasty (n = 1), and stoma closure (n = 1). The median time from admission to diagnosis of SARS-Cov-2 infection was 34 days (5-61 days). In 12 patients (80%), the diagnosis was made after a hospital stay of more than 14 days (15-63 days). At the end of the follow-up, two patients had died, seven were hospitalized with two of them on respiratory assistance, and six patients were discharged post-hospitalization. CONCLUSIONS: The risk of SARS-Cov-2 infection during hospitalization or following digestive surgery is a real and potentially serious risk. Measures are necessary to minimize this risk in order to return to safe surgical activity.","Luong-Nguyen, Minh","Hermand, Helene","Abdalla, Solafah","Cabrit, Nicolas","Hobeika, Christian","Brouquet, Antoine","Goere, Diane","Sauvanet, Alain","32341721"],"abstract":["INTRODUCTION: The COVID-19 pandemic imposed a drastic reduction in surgical activity in order to respond to the influx of hospital patients and to protect uninfected patients by avoiding hospitalization. However, little is known about the risk of infection during hospitalization or its consequences. The aim of this work was to report a series of patients hospitalized on digestive surgery services who developed a nosocomial infection with SARS-Cov-2 virus. METHODS: This is a non-interventional retrospective study carried out within three departments of digestive surgery. The clinical, biological and radiological data of the patients who developed a nosocomial infection with SARS-Cov-2 were collected from the computerized medical record. RESULTS: From March 1, 2020 to April 5, 2020, among 305 patients admitted to digestive surgery services, 15 (4.9%) developed evident nosocomial infection with SARS-Cov-2. There were nine men and six women, with a median age of 62 years (35-68 years). All patients had co-morbidities. The reasons for hospitalization were: surgical treatment of cancer (n = 5), complex emergencies (n = 5), treatment of complications linked to cancer or its treatment (n = 3), gastroplasty (n = 1), and stoma closure (n = 1). The median time from admission to diagnosis of SARS-Cov-2 infection was 34 days (5-61 days). In 12 patients (80%), the diagnosis was made after a hospital stay of more than 14 days (15-63 days). At the end of the follow-up, two patients had died, seven were hospitalized with two of them on respiratory assistance, and six patients were discharged post-hospitalization. CONCLUSIONS: The risk of SARS-Cov-2 infection during hospitalization or following digestive surgery is a real and potentially serious risk. Measures are necessary to minimize this risk in order to return to safe surgical activity."],"authors":["Luong-Nguyen, Minh","Hermand, Helene","Abdalla, Solafah","Cabrit, Nicolas","Hobeika, Christian","Brouquet, Antoine","Goere, Diane","Sauvanet, Alain"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32341721","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.jchirv.2020.04.012","keywords":["covid-19","sars-cov-2","digestive surgery","nosocomial transmission"],"topics":["Prevention","Transmission"],"weight":1,"_version_":1666138495063687168,"score":9.490897,"similar":[{"pmid":32381426,"pmcid":"PMC7183971","title":"Nosocomial infection with SARS-Cov-2 within Departments of Digestive Surgery.","text":["Nosocomial infection with SARS-Cov-2 within Departments of Digestive Surgery.","INTRODUCTION: The COVID-19 pandemic imposed a drastic reduction in surgical activity in order to respond to the influx of hospital patients and to protect uninfected patients by avoiding hospitalization. However, little is known about the risk of infection during hospitalization or its consequences. The aim of this work was to report a series of patients hospitalized on digestive surgery services who developed a nosocomial infection with SARS-Cov-2 virus. METHODS: This is a non-interventional retrospective study carried out within three departments of digestive surgery. The clinical, biological and radiological data of the patients who developed a nosocomial infection with SARS-Cov-2 were collected from the computerized medical record. RESULTS: From March 1, 2020 to April 5, 2020, among 305 patients admitted to digestive surgery departments, 15 (4.9%) developed evident nosocomial infection with SARS-Cov-2. There were nine men and six women, with a median age of 62 years (35-68 years). All patients had co-morbidities. The reasons for hospitalization were: surgical treatment of cancer (n=5), complex emergencies (n=5), treatment of complications linked to cancer or its treatment (n=3), gastroplasty (n=1), and stoma closure (n=1). The median time from admission to diagnosis of SARS-Cov-2 infection was 34 days (5-61 days). In 12 patients (80%), the diagnosis was made after a hospital stay of more than 14 days (15-63 days). At the end of the follow-up, two patients had died, seven were still hospitalized with two of them on respiratory assistance, and six patients were discharged post-hospitalization. CONCLUSIONS: The risk of SARS-Cov-2 infection during hospitalization or following digestive surgery is a real and potentially serious risk. Measures are necessary to minimize this risk in order to return to safe surgical activity.","J Visc Surg","Luong-Nguyen, M","Hermand, H","Abdalla, S","Cabrit, N","Hobeika, C","Brouquet, A","Goere, D","Sauvanet, A","32381426"],"abstract":["INTRODUCTION: The COVID-19 pandemic imposed a drastic reduction in surgical activity in order to respond to the influx of hospital patients and to protect uninfected patients by avoiding hospitalization. However, little is known about the risk of infection during hospitalization or its consequences. The aim of this work was to report a series of patients hospitalized on digestive surgery services who developed a nosocomial infection with SARS-Cov-2 virus. METHODS: This is a non-interventional retrospective study carried out within three departments of digestive surgery. The clinical, biological and radiological data of the patients who developed a nosocomial infection with SARS-Cov-2 were collected from the computerized medical record. RESULTS: From March 1, 2020 to April 5, 2020, among 305 patients admitted to digestive surgery departments, 15 (4.9%) developed evident nosocomial infection with SARS-Cov-2. There were nine men and six women, with a median age of 62 years (35-68 years). All patients had co-morbidities. The reasons for hospitalization were: surgical treatment of cancer (n=5), complex emergencies (n=5), treatment of complications linked to cancer or its treatment (n=3), gastroplasty (n=1), and stoma closure (n=1). The median time from admission to diagnosis of SARS-Cov-2 infection was 34 days (5-61 days). In 12 patients (80%), the diagnosis was made after a hospital stay of more than 14 days (15-63 days). At the end of the follow-up, two patients had died, seven were still hospitalized with two of them on respiratory assistance, and six patients were discharged post-hospitalization. CONCLUSIONS: The risk of SARS-Cov-2 infection during hospitalization or following digestive surgery is a real and potentially serious risk. Measures are necessary to minimize this risk in order to return to safe surgical activity."],"journal":"J Visc Surg","authors":["Luong-Nguyen, M","Hermand, H","Abdalla, S","Cabrit, N","Hobeika, C","Brouquet, A","Goere, D","Sauvanet, A"],"date":"2020-05-09T11:00:00Z","year":2020,"_id":"32381426","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.jviscsurg.2020.04.016","keywords":["covid-19","digestive surgery","nosocomial transmission","sars-cov-2"],"topics":["Prevention"],"weight":1,"_version_":1666419683316727808,"score":990.137},{"pmid":32461068,"title":"Absence of nosocomial transmission of coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in the pre-pandemic phase in Hong Kong.","text":["Absence of nosocomial transmission of coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in the pre-pandemic phase in Hong Kong.","BACKGROUND: To describe the infection control strategy to achieve zero nosocomial transmission of symptomatic coronavirus disease (COVID-19) due to SARS-CoV-2 during the pre-pandemic phase (the first 72 days after announcement of pneumonia cases in Wuhan) in Hong Kong. METHODS: Administrative support with the aim of zero nosocomial transmission by reducing elective clinical services, decanting wards, mobilizing isolation facilities, providing adequate personal protective equipment, coordinating laboratory network for rapid molecular diagnosis under 4-tier active surveillance for hospitalized- and out-patients, and organizing staff forum and training was implemented under the framework of preparedness plan in Hospital Authority. The trend of SARS-CoV-2 in the first 72 days was compared with that of SARS-CoV 2003. RESULTS: Up to day 72 of the epidemic, 130 (0.40%) of 32,443 patients being screened confirmed to have SARS-CoV-2 by RT-PCR. Compared with SARS outbreak in 2003, the SARS-CoV-2 case load constituted 8.9% (130 SARS-CoV-2/1458 SARS-CoV) of SARS-CoV infected cases at day 72 of the outbreak. The incidences of nosocomial acquisition of SARS-CoV per-1,000-SARS-patient-day and per-100-SARS-patient-admission were 7.9 and 16.9 respectively, which were significantly higher than the corresponding incidences of SARS-CoV-2 (zero infection, p<0.001). CONCLUSION: Administrative support to infection control could minimize the risk of nosocomial transmission of SARS-CoV-2.","Am J Infect Control","Cheng, Vincent C C","Wong, Shuk-Ching","Chuang, Vivien W M","So, Simon Y C","Chen, Jonathan H K","Sridhar, Siddharth","To, Kelvin K W","Chan, Jasper F W","Hung, Ivan F N","Ho, Pak-Leung","Yuen, Kwok-Yung","32461068"],"abstract":["BACKGROUND: To describe the infection control strategy to achieve zero nosocomial transmission of symptomatic coronavirus disease (COVID-19) due to SARS-CoV-2 during the pre-pandemic phase (the first 72 days after announcement of pneumonia cases in Wuhan) in Hong Kong. METHODS: Administrative support with the aim of zero nosocomial transmission by reducing elective clinical services, decanting wards, mobilizing isolation facilities, providing adequate personal protective equipment, coordinating laboratory network for rapid molecular diagnosis under 4-tier active surveillance for hospitalized- and out-patients, and organizing staff forum and training was implemented under the framework of preparedness plan in Hospital Authority. The trend of SARS-CoV-2 in the first 72 days was compared with that of SARS-CoV 2003. RESULTS: Up to day 72 of the epidemic, 130 (0.40%) of 32,443 patients being screened confirmed to have SARS-CoV-2 by RT-PCR. Compared with SARS outbreak in 2003, the SARS-CoV-2 case load constituted 8.9% (130 SARS-CoV-2/1458 SARS-CoV) of SARS-CoV infected cases at day 72 of the outbreak. The incidences of nosocomial acquisition of SARS-CoV per-1,000-SARS-patient-day and per-100-SARS-patient-admission were 7.9 and 16.9 respectively, which were significantly higher than the corresponding incidences of SARS-CoV-2 (zero infection, p<0.001). CONCLUSION: Administrative support to infection control could minimize the risk of nosocomial transmission of SARS-CoV-2."],"journal":"Am J Infect Control","authors":["Cheng, Vincent C C","Wong, Shuk-Ching","Chuang, Vivien W M","So, Simon Y C","Chen, Jonathan H K","Sridhar, Siddharth","To, Kelvin K W","Chan, Jasper F W","Hung, Ivan F N","Ho, Pak-Leung","Yuen, Kwok-Yung"],"date":"2020-05-29T11:00:00Z","year":2020,"_id":"32461068","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.ajic.2020.05.018","keywords":["absence","covid-19","hong kong","sars-cov-2","coronavirus disease 2019","nosocomial transmission"],"locations":["Wuhan","China","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Transmission","Prevention"],"weight":1,"_version_":1668079521260109825,"score":259.07642},{"pmid":32249098,"title":"Strategy for the practice of digestive and oncological surgery during the Covid-19 epidemic.","text":["Strategy for the practice of digestive and oncological surgery during the Covid-19 epidemic.","The Covid-19 pandemic is changing the organization of healthcare and has a direct impact on digestive surgery. Healthcare priorities and circuits are being modified. Emergency surgery is still a priority. Functional surgery is to be deferred. Laparoscopic surgery must follow strict rules so as not to expose healthcare professionals (HCPs) to added risk. The question looms large in cancer surgery-go ahead or defer? There is probably an added risk due to the pandemic that must be balanced against the risk incurred by deferring surgery. For each type of cancer-colon, pancreas, oesogastric, hepatocellular carcinoma-morbidity and mortality rates are stated and compared with the oncological risk incurred by deferring surgery and/or the tumour doubling time. Strategies can be proposed based on this comparison. For colonic cancers T1-2, N0, it is advisable to defer surgery. For advanced colonic lesions, it seems judicious to undertake neoadjuvant chemotherapy and then wait. For rectal cancers T3-4 and/or N+, chemoradiotherapy is indicated, short radiotherapy must be discussed (followed by a waiting period) to reduce time of exposure in the hospital and to prevent infections. Most complex surgery with high morbidity and mortality-oesogastric, hepatic or pancreatic-is most often best deferred.","J Visc Surg","Tuech, J-J","Gangloff, A","Di Fiore, F","Michel, P","Brigand, C","Slim, K","Pocard, M","Schwarz, L","32249098"],"abstract":["The Covid-19 pandemic is changing the organization of healthcare and has a direct impact on digestive surgery. Healthcare priorities and circuits are being modified. Emergency surgery is still a priority. Functional surgery is to be deferred. Laparoscopic surgery must follow strict rules so as not to expose healthcare professionals (HCPs) to added risk. The question looms large in cancer surgery-go ahead or defer? There is probably an added risk due to the pandemic that must be balanced against the risk incurred by deferring surgery. For each type of cancer-colon, pancreas, oesogastric, hepatocellular carcinoma-morbidity and mortality rates are stated and compared with the oncological risk incurred by deferring surgery and/or the tumour doubling time. Strategies can be proposed based on this comparison. For colonic cancers T1-2, N0, it is advisable to defer surgery. For advanced colonic lesions, it seems judicious to undertake neoadjuvant chemotherapy and then wait. For rectal cancers T3-4 and/or N+, chemoradiotherapy is indicated, short radiotherapy must be discussed (followed by a waiting period) to reduce time of exposure in the hospital and to prevent infections. Most complex surgery with high morbidity and mortality-oesogastric, hepatic or pancreatic-is most often best deferred."],"journal":"J Visc Surg","authors":["Tuech, J-J","Gangloff, A","Di Fiore, F","Michel, P","Brigand, C","Slim, K","Pocard, M","Schwarz, L"],"date":"2020-04-07T11:00:00Z","year":2020,"_id":"32249098","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1016/j.jviscsurg.2020.03.008","keywords":["cancer","coronavirus","covid-19","digestive surgery","surgical complications"],"topics":["Prevention"],"weight":1,"_version_":1666138491034009600,"score":239.0867},{"pmid":32366488,"title":"Nosocomial Outbreak of 2019 Novel Coronavirus Pneumonia in Wuhan, China.","text":["Nosocomial Outbreak of 2019 Novel Coronavirus Pneumonia in Wuhan, China.","BACKGROUND: The novel coronavirus (SARS-CoV-2) infected over 3300 health-care-workers (HCWs) in early 2020 in China. Little information is known about nosocomial infections of HCWs in the initial period. We analysed data from HCWs with nosocomial infections in Wuhan Union Hospital and their family members. METHODS: We collected and analysed data on exposure history, illness timelines, and epidemiologic characteristics of 25 laboratory-confirmed and two highly suspected HCWs as well as ten of their family members with COVID-19 from Jan 5 to Feb 12, 2020. Among them, demographics and clinical features of the 35 laboratory-confirmed cases were investigated and viral RNA of 12 cases was sequenced and analysed. RESULTS: Nine clusters were found among the patients. All patients showed mild to moderate clinical manifestation and recovered without deterioration. The average periods of incubation, clinical onset serial interval (COSI), and virus shedding were 4.5 days, 5.2+/-3.2 days, and 18.5 days, respectively. Complete genomic sequences of 12 different coronavirus strains demonstrated that the viral structure with small, irrelevant mutations was stable in the transmission chains and showed remarkable traits of infectious traceability. CONCLUSIONS: SARS-CoV-2 can be rapidly transmitted person-to-person regardless of whether they have symptoms in both hospital settings and social activities based on the short period of incubation and COSI. The public health service should take practical measures to curb the spread, including isolation of cases, tracing close-contacts, and containment of severe epidemic areas. Besides, the HCWs should be alert during the epidemic, and make self-quarantine if self-suspected.","Eur Respir J","Wang, Xiaorong","Zhou, Qiong","He, Yukun","Liu, Lingbo","Ma, Xinqian","Wei, Xiaoshan","Jiang, Nanchuan","Liang, Limei","Zheng, Yali","Ma, Ling","Xu, Yu","Yang, Dong","Zhang, Jianchu","Yang, Bohan","Jiang, Ning","Deng, Tao","Zhai, Bingbing","Gao, Yang","Liu, Wenxuan","Bai, Xinghua","Pan, Tao","Wang, Guoqing","Chang, Yujun","Zhang, Zhi","Shi, Huanzhong","Ma, Wan-Li","Gao, Zhancheng","32366488"],"abstract":["BACKGROUND: The novel coronavirus (SARS-CoV-2) infected over 3300 health-care-workers (HCWs) in early 2020 in China. Little information is known about nosocomial infections of HCWs in the initial period. We analysed data from HCWs with nosocomial infections in Wuhan Union Hospital and their family members. METHODS: We collected and analysed data on exposure history, illness timelines, and epidemiologic characteristics of 25 laboratory-confirmed and two highly suspected HCWs as well as ten of their family members with COVID-19 from Jan 5 to Feb 12, 2020. Among them, demographics and clinical features of the 35 laboratory-confirmed cases were investigated and viral RNA of 12 cases was sequenced and analysed. RESULTS: Nine clusters were found among the patients. All patients showed mild to moderate clinical manifestation and recovered without deterioration. The average periods of incubation, clinical onset serial interval (COSI), and virus shedding were 4.5 days, 5.2+/-3.2 days, and 18.5 days, respectively. Complete genomic sequences of 12 different coronavirus strains demonstrated that the viral structure with small, irrelevant mutations was stable in the transmission chains and showed remarkable traits of infectious traceability. CONCLUSIONS: SARS-CoV-2 can be rapidly transmitted person-to-person regardless of whether they have symptoms in both hospital settings and social activities based on the short period of incubation and COSI. The public health service should take practical measures to curb the spread, including isolation of cases, tracing close-contacts, and containment of severe epidemic areas. Besides, the HCWs should be alert during the epidemic, and make self-quarantine if self-suspected."],"journal":"Eur Respir J","authors":["Wang, Xiaorong","Zhou, Qiong","He, Yukun","Liu, Lingbo","Ma, Xinqian","Wei, Xiaoshan","Jiang, Nanchuan","Liang, Limei","Zheng, Yali","Ma, Ling","Xu, Yu","Yang, Dong","Zhang, Jianchu","Yang, Bohan","Jiang, Ning","Deng, Tao","Zhai, Bingbing","Gao, Yang","Liu, Wenxuan","Bai, Xinghua","Pan, Tao","Wang, Guoqing","Chang, Yujun","Zhang, Zhi","Shi, Huanzhong","Ma, Wan-Li","Gao, Zhancheng"],"date":"2020-05-06T11:00:00Z","year":2020,"_id":"32366488","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1183/13993003.00544-2020","locations":["China","Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention","Transmission"],"weight":1,"_version_":1666138496134283265,"score":228.40495},{"pmid":32336467,"pmcid":"PMC7138380","title":"SARS-CoV-2 pandemic on the activity and professionals of a General Surgery and Digestive Surgery Service in a tertiary hospital.","text":["SARS-CoV-2 pandemic on the activity and professionals of a General Surgery and Digestive Surgery Service in a tertiary hospital.","INTRODUCTION: The rapid spread of SARS-CoV-2 infection has led to a radical reorganization of healthcare resources. Surgical Departments need to adapt to this change. METHODS: We performed a prospective descriptive observational study of the incidence of COVID-19 in patients and surgeons of a General Surgical Department in a high prevalence area, between the 1st and 31st of March 2020. RESULTS: Patients: The incidence of SARS-CoV-2 infection in elective surgery patients was 7% (mean age 59.5 years). All survived. Of 36 patients who underwent emergency surgery, two of them were SARS-CoV-2 positive and one was clinically highly suspicious of COVID-19 (11.1%). All three patients died of respiratory failure (mean age 81 years). Surgeons: There were a total of 12 confirmed SARS-CoV-2+ cases among the surgical department staff (24.4%) (8 out of 34 consultants and 4 out of 15 residents). Healthcare activity: The average number of daily emergency surgical interventions declined from 3.6 in February to 1.16 in March. 42% of the patients who underwent emergency surgery had peritonitis upon presentation. CONCLUSIONS: The fast pace of COVID-19 pandemia should alert surgical departments of the need of adopting early measures to ensure the safety of patients and staff.","Cir Esp","Alvarez Gallego, Mario","Gortazar de Las Casas, Sara","Pascual Miguelanez, Isabel","Rubio-Perez, Ines","Barragan Serrano, Cristina","Alvarez Pena, Estibaliz","Diaz Dominguez, Joaquin","32336467"],"abstract":["INTRODUCTION: The rapid spread of SARS-CoV-2 infection has led to a radical reorganization of healthcare resources. Surgical Departments need to adapt to this change. METHODS: We performed a prospective descriptive observational study of the incidence of COVID-19 in patients and surgeons of a General Surgical Department in a high prevalence area, between the 1st and 31st of March 2020. RESULTS: Patients: The incidence of SARS-CoV-2 infection in elective surgery patients was 7% (mean age 59.5 years). All survived. Of 36 patients who underwent emergency surgery, two of them were SARS-CoV-2 positive and one was clinically highly suspicious of COVID-19 (11.1%). All three patients died of respiratory failure (mean age 81 years). Surgeons: There were a total of 12 confirmed SARS-CoV-2+ cases among the surgical department staff (24.4%) (8 out of 34 consultants and 4 out of 15 residents). Healthcare activity: The average number of daily emergency surgical interventions declined from 3.6 in February to 1.16 in March. 42% of the patients who underwent emergency surgery had peritonitis upon presentation. CONCLUSIONS: The fast pace of COVID-19 pandemia should alert surgical departments of the need of adopting early measures to ensure the safety of patients and staff."],"journal":"Cir Esp","authors":["Alvarez Gallego, Mario","Gortazar de Las Casas, Sara","Pascual Miguelanez, Isabel","Rubio-Perez, Ines","Barragan Serrano, Cristina","Alvarez Pena, Estibaliz","Diaz Dominguez, Joaquin"],"date":"2020-04-28T11:00:00Z","year":2020,"_id":"32336467","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.ciresp.2020.04.001","keywords":["covid-19","cirugia","enfermedades infecciosas","healthcare personnel","infectious diseases","personal sanitario","surgery"],"topics":["Prevention"],"weight":1,"_version_":1666138494194417664,"score":222.92966}]}